Kinetics and mechanisms of recombinant human interleukin 1 and tumor necrosis factor-alpha-induced changes in circulating numbers of neutrophils and lymphocytes.
about
Does PGE₁ vasodilator prevent orthopaedic implant-related infection in diabetes? Preliminary results in a mouse modelA pre-operative elevated neutrophil: lymphocyte ratio does not predict survival from oesophageal cancer resectionCurrent status of monoclonal antibody therapy for the treatment of inflammatory bowel disease.External validation of the derived neutrophil to lymphocyte ratio as a prognostic marker on a large cohort of pancreatic cancer patients.Sputum tumour necrosis factor-alpha and leukotriene concentrations in cystic fibrosisImmunological priming attenuates the in vivo pathophysiological response to lipopolysaccharide. Comparison of cytokine production, tissue injury, and lethality in complete Freund's adjuvant-primed mice and in unprimed mice.Derived neutrophil to lymphocyte ratio predicts prognosis for patients with HBV-associated hepatocellular carcinoma following transarterial chemoembolization.Blood concentrations of the cytokines IL-1beta, IL-6, IL-10, TNF-alpha and IFN-gamma during experimentally induced swine dysentery.MDHM, a macrophage-stimulatory product of Mycoplasma fermentans, leads to in vitro interleukin-1 (IL-1), IL-6, tumor necrosis factor, and prostaglandin production and is pyrogenic in rabbitsThe impact of preoperative serum anti-TNFα therapy levels on early postoperative outcomes in inflammatory bowel disease surgery.Clinical Significance of Preoperative Neutrophil - to - Lymphocyte Ratio in Renal Cell Carcinoma.Neutrophil and lymphocyte counts at diagnosis are associated with overall survival of pancreatic cancer: A retrospective cohort studyDual functionality of interleukin-1 family cytokines: implications for anti-interleukin-1 therapyInterleukin-18 induces acute biphasic reduction in the levels of circulating leukocytes in mice.Protection of mice against Listeria monocytogenes infection by recombinant human tumor necrosis factor alpha.Evidence that tumor necrosis factor plays a pathogenetic role in the paraneoplastic syndromes of cachexia, hypercalcemia, and leukocytosis in a human tumor in nude mice.Effects of anti-inflammatory drugs on fever and neutrophilia induced by Clostridium difficile toxin B.The effect of an interleukin receptor antagonist (IL-1ra) on colonocyte eicosanoid release.Endotoxin-induced cytokine gene expression in vivo. IV. Expression of interleukin-1 alpha/beta and interleukin-1 receptor antagonist mRNA during endotoxemia and during endotoxin-initiated local acute inflammation.The intratracheal administration of endotoxin and cytokines. I. Characterization of LPS-induced IL-1 and TNF mRNA expression and the LPS-, IL-1-, and TNF-induced inflammatory infiltrateEndotoxin-induced cytokine gene expression in vivo. I. Expression of tumor necrosis factor mRNA in visceral organs under physiologic conditions and during endotoxemiaAcute in vivo effects of IL-3 alone and in combination with IL-6 on the blood cells of the circulation and bone marrow.Intratracheal injection of endotoxin and cytokines. II. Interleukin-6 and transforming growth factor beta inhibit acute inflammation.The intratracheal administration of endotoxin and cytokines. III. The interleukin-1 (IL-1) receptor antagonist inhibits endotoxin- and IL-1-induced acute inflammation.Endotoxin-induced cytokine gene expression in vivo. II. Regulation of tumor necrosis factor and interleukin-1 alpha/beta expression and suppression.Kinetics and mechanisms of recombinant human granulocyte-colony stimulating factor-induced neutrophilia.Role of tumor necrosis factor-alpha in lipopolysaccharide-induced pathologic alterations.The hematologic effects of chronic administration of the monokines tumor necrosis factor, interleukin-1, and granulocyte-colony stimulating factor on bone marrow and circulation.Hematologic effects of recombinant murine granulocyte-macrophage colony-stimulating factor on the peripheral blood and bone marrow.Transient adhesion of neutrophils to endothelium.Neutrophil-lymphocyte ratio predicts response to chemotherapy in triple-negative breast cancer.Prognostic significance of combined fibrinogen concentration and neutrophil-to-lymphocyte ratio in patients with resectable non-small cell lung cancer.Preoperative neutrophil-to-lymphocyte ratio predicts the surgical outcome of Xp11.2 translocation/TFE3 renal cell carcinoma patients.Impact of neutrophil-lymphocyte ratio on long-term outcome in patients with craniopharyngioma
P2860
Q28537680-0D33F25A-D672-480D-8CBC-2E167F6CA9E7Q33641729-7BAC4A77-7C98-413D-AF19-DD9A8D0632E5Q34127277-3F1B36A9-7D05-4C68-9251-C1BA03AE4DB5Q35040836-DEED9E4F-3F87-4030-922E-3592738C3EBDQ35628419-3CCE3037-36F5-4CED-865C-AFA5508DC68FQ35833307-AB977A9D-4A9A-4519-A128-0F0D8EDF996FQ36824936-05D31CF1-3419-45B8-BFF6-E91D38E94262Q36855432-E300C2ED-6BB6-4465-8B98-F515BAF9DD63Q36988779-8CA3C169-BB99-4DD6-A511-95D7ED3FC46AQ37197292-43F7EB52-210B-4B4D-956F-4B90BAB60DF3Q37221772-8B560C2C-EE21-4916-8F55-5364BC7121F7Q37328875-6580D3B2-E6B3-4316-8653-EB19978CC74CQ37579967-DAD00B40-4688-4C5C-AF6C-0C925E03DB3AQ39625918-5B9EFE9E-E68E-4E01-BCDA-5C5F586F76F7Q40427098-81DAB542-94D7-4034-A1DA-BDF4AEE3BC89Q40512172-90E0C0C8-4F32-450F-B861-E05937F0B3A6Q40673310-6C4CD3F9-BDDF-4BE5-9DAD-037A2D78E602Q40952985-D2CF130D-6BAF-41D4-87AE-C22F8AD209D5Q41094606-B463F8D8-ECF1-4BE9-9BF4-62E12DFA5E47Q41188038-053C7694-9262-41AD-8633-F463952DE97BQ41291046-73C638DC-F836-4005-8C80-DC91795CF2A4Q41328610-E774A8EB-121D-406A-96DD-806A0F912818Q41819655-64680504-5E71-448D-93F9-15D4F5AB3D8DQ41835332-B013514A-030F-438B-A9D9-F2FCBC7F67FAQ42106966-A41BCAA5-9607-4BA9-B780-1B97E96A7016Q42117983-06FA6758-948D-4CA7-9183-B5D5D7D7F9E2Q42173056-B26C11FE-508E-4708-B578-220A2BDCBE0CQ42770257-F72BBC93-9E7F-49C3-A669-050B5B1871AEQ42773989-CB98A2B1-9E52-475D-83D1-AA1FB72D9732Q42939605-487357DF-5718-4C79-9AB1-E677B21741A5Q53069534-A102779E-4659-4D64-86F5-A3F34533540DQ55261440-0C7B1F46-EC67-400F-9CFA-8F743CA54F38Q55315179-4F05F760-E1E0-47FB-A858-12C1263D4B3CQ58739379-52EE6863-C05F-4BFA-9A09-9C689D0921BA
P2860
Kinetics and mechanisms of recombinant human interleukin 1 and tumor necrosis factor-alpha-induced changes in circulating numbers of neutrophils and lymphocytes.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh
1987年學術文章
@zh-hant
name
Kinetics and mechanisms of rec ...... f neutrophils and lymphocytes.
@en
Kinetics and mechanisms of rec ...... f neutrophils and lymphocytes.
@nl
type
label
Kinetics and mechanisms of rec ...... f neutrophils and lymphocytes.
@en
Kinetics and mechanisms of rec ...... f neutrophils and lymphocytes.
@nl
prefLabel
Kinetics and mechanisms of rec ...... f neutrophils and lymphocytes.
@en
Kinetics and mechanisms of rec ...... f neutrophils and lymphocytes.
@nl
P2093
P1476
Kinetics and mechanisms of rec ...... f neutrophils and lymphocytes.
@en
P2093
P304
P407
P577
1987-11-01T00:00:00Z